Posts

Showing posts with the label Cancer/Tumor Profiling Market

Cancer/Tumor Profiling Market Report | the Demand for the Market Will Drastically Increase in the Future

Cancer/tumor profiling gives information on the genes that cause cancer, which can help researchers better understand how cancer works. Cancer profiling is not only effective in the molecular profiling of common malignancies like lymphoma and breast cancer, but also in the molecular profiling of lung cancer, prostate cancer, and acute leukaemia. Cancer profiling has become increasingly important in molecular diagnosis, since a better understanding of cancer tumours aids physicians in making appropriate therapeutic decisions and avoiding “over-treatment” of cancer patients. Oncologists' increasing demand for cancer profiling methods to diagnose or treat malignancies, as well as forecast response to targeted therapy, is driving the Cancer/Tumor Profiling Market . Furthermore, an increase in the use of cancer biomarkers for tumour profiling, an increase in cancer incidence around the world, and an increase in the use of next-generation sequencing techniques for cancer profiling all co